CrisprBits: Biotech startup CrisprBits develops platform to test antibiotic resistance

CrisprBits, a Bengaluru-based biotech startup, has developed a platform from CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections. The startup’s PathCrisp platform can detect resistance in bacterial samples from patients within two hours compared to 24-27 hours through other methods. This can reduce prolonged hospital stays and bring down healthcare costs. “It operates at a constant temperature, eliminating the need for a thermocycler, and works directly on various samples, including…